The Care Quality Inspection has scheduled an inspection of University College London Hospital (UCLH) from 8th to 11th March 2016.
UCLH is the subcontracted provider of endocrinological treatments to the young patients of the Gender Identity Development Service (GIDS) at the Tavistock and Portman NHS Foundation Trust.
The Parliamentary Women and Equalities Select Committee, chaired by Maria Miller, recommended that “consideration be given to reducing the amount of time required for the assessment that service-users must undergo before puberty blockers and cross-sex hormones can be prescribed”. Part of that assessment is carried out within UCLH, prior to offering those medications. In any case, UCLH does not offer cross-sex hormones before age 16.
There is considerable dissatisfaction with the GIDS and UCLH services among gender variant young people and their families. Some young patients decide to seek proper treatment overseas, particularly in the USA.
You can register any of your own concerns about the UCLH service by calling 03000 61 61 61, or emailing firstname.lastname@example.org.